The Caudal-type homeobox transcription factor 2 (CDX2) gene is documented as a prognostic biomarker of colon cancer with high value in mesenchymal (MS4) molecular subgroup [41] and a tumorigenic role by promotion of anchorage-independent cell growth and anoikis resistance [42]. The gene discussed is CDX2; the disease is colonic neoplasm.